Site Search

Share

X

Search Results

Legislation Aimed at Improving Health Outcomes for New Jerseyans Passes in Senate and Assembly, Awaits Governor’s Action

Yesterday, both chambers in the New Jersey State Legislature passed legislation (Assembly Bill 4163 / Senate Bill 3098) to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Murphy’s desk, providing him the ... CAN) is leading the efforts on this significant policy change to ensure more patients can get the testing needed to access precision medicine. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to ...

Governor Signs Legislation that Provides Access to Precision Treatment for All Oklahomans

Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. “ACS CAN thanks Sen. Paul Rosino for his leadership on biomarker ...

Lawmakers Can Take Crucial Step in Revolutionizing Cancer Care in Nevada

LAS VEGAS – March 13, 2023 – Nevada Assemblywoman Sarah Peters (D) has introduced Assembly Bill 155 which would expand access to biomarker testing statewide. Testing has become an increasingly important and game-changing part of cancer care in recent years due to its significant impact ... by ruling out unnecessary treatments and eliminating potentially life-altering side effects.  Most insurance plans in the state currently cover biomarker testing; however, unfortunately, there is a small population of Nevadans who still don’t have access either because their healthcare ...

Public Health Champions Unite to Applaud Senate and Urge Assembly and Governor Hochul “Reject the Rollback”

... to applaud the Senate and call on Governor Hochul and Assembly leadership to join the Senate in preserving Medicaid enrollees’ access to biomarker testing. The conversation around equitable access to biomarker testing was reignited earlier this year, when Governor Hochul proposed to eliminate the existing coverage criteria for Medicaid enrollees ...

2023 Kentucky Cancer Action Day Webpage

... and Slides Below : Pre-Event Training Recording 23_ky_volunteer_training_presentation_final.pdf Fact sheets Mentioned in the Pre-Training: biomarker_testing_costs_and_cost_savings.pdf acs_can_biomarker_testing_patient_profiles_final_0.pdf health_equity_in_biomarker_testing_and_targeted_therapy_.pdf biomarker_testing_faq_.pdf ...

Proposal Aimed at Improving Health Outcomes for Mainers Secures Overwhelming Support from Voters

... 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges Committee members to support the bill, which aims to expand coverage for biomarker testing—when medically appropriate—to Mainers insured through state-regulated health plans, including Medicaid.   Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. It ...

Governor Hochul Signs Game-Changing Legislation Aimed at Improving Health Outcomes, Quality of Life for New Yorkers

... a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable more New Yorkers to access precision medicine treatments that can lead to fewer side effects, improved survival, better ... fight against cancer and improve access to the most effective treatments, giving patients a better chance of living longer, healthier lives.” Biomarker testing has become a game-changing part of cancer care given its role in opening the door to personalized care, including targeted ...

Colorectal Cancer Awareness Month 2023: What Has New York Done to Address Rise in Colorectal Cancer Diagnoses?

... the New York State Legislature aims to improve access to precision medicine for patients with cancer and other diseases by expanding access to biomarker testing. Building off the progress of the Colorectal Cancer Cost-Sharing Removal Act, which was passed at the end of 2022 and will remove financial barriers to screening, Senate Bill 1196 / Assembly Bill 1673 will ensure that New Yorkers who could benefit from biomarker testing have access to it, including those with CRC. The proposed legislation will require all state-regulated health plans, including ...

Delegate Westfall files legislation aimed at improving health outcomes in West Virginia

CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by health insurance and ...

Delaware Patients Now One Step Closer to Expanding Access to Precision Medicine

Today, legislation aiming to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans, was voted out of committee and will soon be heard by the full House. This marks the final step before the bill goes to Governor Matt Meyer who, earlier this year, identified biomarker testing access as a priority. Biomarker testing is a precision medicine tool that utilizes information from patients’ disease cells to ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy